๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 11 Guangzhou 4 Tianjing 2 Hangzhou 2 Kunming 2
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing11 Guangzhou4 Tianjing2 Hangzhou2 Kunming2
All 22 locations
Target enrolment
to

Trials with a site in Beijing

11 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Phase I/II Study of SCTB39G in Advanced Solid Tumours
NCT07077252Advanced Malignant Solid Tumor
Sinocelltech Ltd.
Phase 1/2
30
Beijing
2025-07-28
Recruiting
Phase I/II Study of SCTB39-1 in Advanced Solid Tumours
NCT07050641Advanced Malignant Solid Tumor
Sinocelltech Ltd.
Phase 1/2
110
Beijing
2025-06-23
Recruiting
A Study of SCTB35 in Patients with Systemic Lupus Erythematosus
NCT06841042System Lupus Erythematosus
Sinocelltech Ltd.
Phase 1/2
168
Beijing, Changchun, Guangzhou, Hangzhou, Jiujiang, Kunming, Linfen, Mianyang
2025-02
Not yet open
A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases
NCT06774664IgA Nephropathy
Sinocelltech Ltd.
Phase 1/2
99
Baotou, Beijing, Chengdu, Guangzhou, Hangzhou, Jinan, Nanchang, Nanning
2025-01
Recruiting
Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.
NCT07437404Haemophilia A
Sinocelltech Ltd.
Phase 3
36
Beijing
2024-04-26
Not yet open
A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma
NCT06318884Non-Hodgkin Lymphoma, B-cell
Sinocelltech Ltd.
Phase 1
76
Beijing, Zhengzhou, Tianjin
2024-04
Recruiting
A Clinical Study of SCTC21C in Participants With CD38+ Hematologic Malignancies
NCT06252298Relapsed or Refractory Hematologic Malignancies
Sinocelltech Ltd.
Phase 1
74
Beijing
2024-02-28
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies with a site in Beijing that also match the filters currently applied.

How many clinical trials are recruiting in Beijing?

8 of the 11 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Beijing), 11 studies
PhaseStudiesRecruitingShare
Phase 35545.5%
Phase 1/24236.4%
Phase 12118.2%

Most active sponsors

Lead sponsors with the most studies (Beijing)
Lead sponsorStudiesRecruiting
Sinocelltech Ltd.118
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.